Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Early phase II and other data presented at 39th ICAAC for GW-420867X

Oct. 1, 1999

Licensing opportunity from NIH: chicoric acid analogues as inhibitors of HIV-1 integrase

Oct. 1, 1999

Pivotal trial of Remune begins

Oct. 1, 1999

DuPont and Pharmasset establish collaboration for development of antiviral compounds

Oct. 1, 1999

Samjin's SJ-3366: a promising anti-HIV compound with a dual mechanism of action

Sep. 30, 1999

Licensing opportunity from NIH: globotriaosylceramide as a promoter of HIV-1 entry into cells

Sep. 30, 1999

Gilead's once-daily anti-HIV agent effective and safe in patients, as reported at ICAAC

Sep. 29, 1999

Licensing opportunity from NIH: thiazepine inhibitors of HIV-1 integrase

Sep. 29, 1999

Major medical conference presentation for early data on new amprenavir prodrug

Sep. 28, 1999

Novel HIV-1 protease inhibitor UIC-94-003 exerts potent antiviral activity

Sep. 28, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...